Peritoneal dialysis in 2022: an accidental renaissance?

Abstract

The review focuses on peritoneal dialysis as a renal replacement therapy for stage 5 chronic kidney disease (CKD). About 10 % of the world’s population suffers from CKD, but its prevalence and incidence vary widely across the world due to social and economic conditions. The main areas of renal replacement therapy today are haemodialysis and peritoneal dialysis, the beginning of which is recommended for CKD stage 5. Both me­thods are effective and have similar survival and mortality rates. Both techniques are used successfully around the world, but peritoneal dialysis is less resource-intensive, making it the method of choice in many less affluent countries. The advantages of peritoneal dialysis can be: shorter sessions, limited patient movement, being in the family circle and better quality of life according to the patients themselves. Numerous studies are being conducted to improve the reliability and quality of peritoneal dialysis, including access and prevention of infections.